Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Czernichow S et al. – Weight loss drugs have been developed to reduce the comorbidities associated with excess weight. There was little evidence that treatment was associated with adverse effects on cardiovascular risk factors but this requires verification from future large trials with longer study follow–up.

Related Articles

Morbidity in obese adolescents who meet the adult National Institutes of Health criteria for bariatric surgery
Journal of Pediatric Surgery, 10/26/09    Relevance Score: 68%

Metabolic Syndrome in Obese Children and Adolescents: Dichotomous or Continuous
Metabolic Syndrome and Related Disorders, 11/13/09    Relevance Score: 67%

Fasting Plasma Glucose (FPG) and the Risk of Impaired Glucose Tolerance in Obese Children and Adolescents
Obesity, 11/03/09    Relevance Score: 67%

Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents
Metabolism-Clinical and Experimental, 10/09/09    Relevance Score: 67%

Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS)
Clinical Endocrinology, 11/17/09    Relevance Score: 66%

Today in Adverse Drug Reactions...keeping you current

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09

Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09

Complications and side-effects of foam sclerotherapy
Phlebology, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address